R. Hector MacKay-Dunn, Director at Aurinia Pharmaceuticals Inc. (AUPH), sold 9,636 shares at $11.26 ($109K) on 2023-05-23, disclosed to the SEC on 2023-05-23.
Open-market sale of $109k AUPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.26 | 4,818 | $54K | 50.0% |
| 2 | $11.26 | 4,818 | $54K | 50.0% |
| Total | $11.26 avg | 9,636 | $109K | 100% |
| Filing → |
| AUPH | BUY | 2021-05-13 | $51K | — | Filing → |